CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NEWmRNA aims to expand the understanding of mRNA translation in human cells to enhance medical therapies and diagnostics. The project focuses on synthetic biology to improve the production and application of mRNA in various fields, including gene therapy and diagnostics.
mRNA is a major actor in the expression of cellular information, but we can only wield it in the very narrow boundaries imposed upon us by the transcriptional machinery and our lack of knowledge of the chemical scope of mRNA translation inhuman cells.
Given the diverse role of mRNA in major life science applications from vaccination via gene therapy, chemistry, and diagnostics to pest control in agriculture, we argue that we are missing a huge opportunity to improve the outcome of medical therap…
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, Leuven
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, Zurich
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Konstanz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Luxembourg, Luxembourg
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
